Standard
Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators. / Druedahl, Louise C.; Kälvemark Sporrong, Sofia; van de Weert, Marco; De Bruin, Marie Louise (Marieke); Hoogland, Hans; Minssen, Timo; Almarsdóttir, Anna Birna.
In:
BioDrugs, Vol. 35, 2021, p. 351-361.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Druedahl, LC, Kälvemark Sporrong, S, van de Weert, M, De Bruin, MLM, Hoogland, H
, Minssen, T & Almarsdóttir, AB 2021, '
Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators',
BioDrugs, vol. 35, pp. 351-361.
https://doi.org/10.1007/s40259-021-00478-7
APA
Druedahl, L. C., Kälvemark Sporrong, S., van de Weert, M., De Bruin, M. L. M., Hoogland, H.
, Minssen, T., & Almarsdóttir, A. B. (2021).
Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators.
BioDrugs,
35, 351-361.
https://doi.org/10.1007/s40259-021-00478-7
Vancouver
Druedahl LC, Kälvemark Sporrong S, van de Weert M, De Bruin MLM, Hoogland H
, Minssen T et al.
Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators.
BioDrugs. 2021;35:351-361.
https://doi.org/10.1007/s40259-021-00478-7
Author
Druedahl, Louise C. ; Kälvemark Sporrong, Sofia ; van de Weert, Marco ; De Bruin, Marie Louise (Marieke) ; Hoogland, Hans ; Minssen, Timo ; Almarsdóttir, Anna Birna. / Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators. In: BioDrugs. 2021 ; Vol. 35. pp. 351-361.
Bibtex
@article{d9b8adb0ada845a19a720d8a2c0d02b2,
title = "Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators",
author = "Druedahl, {Louise C.} and {K{\"a}lvemark Sporrong}, Sofia and {van de Weert}, Marco and {De Bruin}, {Marie Louise (Marieke)} and Hans Hoogland and Timo Minssen and Almarsd{\'o}ttir, {Anna Birna}",
year = "2021",
doi = "10.1007/s40259-021-00478-7",
language = "English",
volume = "35",
pages = "351--361",
journal = "BioDrugs",
issn = "1173-8804",
publisher = "Adis International Ltd",
}
RIS
TY - JOUR
T1 - Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators
AU - Druedahl, Louise C.
AU - Kälvemark Sporrong, Sofia
AU - van de Weert, Marco
AU - De Bruin, Marie Louise (Marieke)
AU - Hoogland, Hans
AU - Minssen, Timo
AU - Almarsdóttir, Anna Birna
PY - 2021
Y1 - 2021
U2 - 10.1007/s40259-021-00478-7
DO - 10.1007/s40259-021-00478-7
M3 - Journal article
C2 - 33830478
VL - 35
SP - 351
EP - 361
JO - BioDrugs
JF - BioDrugs
SN - 1173-8804
ER -
